References
- References
- Larkin CJ, Watson RGP, Sloan J, Ardill JES, Johnston C, Buchanan KD. Atrophic gastritis and Helicobacter pylori infection in patients treated with proton pump inhibitors. Gut 1997;41:A171.
- Kuipers EJ, Lundell L, Klinkenberg-Knol EC, Havu N, Festen HPM, Liedman B, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux oesophagitis treated with omeprazole or fundoplication. N Engl J Med 1996;334:1018–22.
- Eissele R, Brunner G, Simon B, Solcia E, Arnold R. Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. Gastroenterology 1997;112: 707–17.
- Correa P, Cuello C, Duque E, Burbano LC, Garcia FT, Bolanos O, et al. Gastric cancer in Colombia. J Natl Cancer Inst 1976;57:1027–33.
- Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. Am J Surg Pathol 1996;20:1161–81.
- Bayerdorffer E, Lehn N, Hatz R, Mannes GA, Oertel H, Sauerbruch T, et al. Difference in expression of Helicobacter pylori gastritis in antrum and body. Gastroenterology 1992;102:1575–82.
- El-Zimaity HMT, Graham DY, Al Assi MT, Malaty H, Karttunen T, Graham DP, et al. Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol 1996;27: 35–41.
- Andrew A, Wyatt JI, Dixon MF. Observer variation in the assessment of chronic gastritis according to the Sydney system. Histopathology 1994;25:317–22.
- Chan WY, Hui PK, Leung KM. Modes of Helicobacter pylori colonisation and gastric epithelial damage. Histopathology 1992;21:521–8.
- Susuki M, Muira S, Suematsu M. Helicobacterpylori-associated ammonia production enhances neutrophil-dependent gastric mucosal injury. Am J Physiol 1992;263:G719–25.
- Valle J, Kekki M, Sipponen P, Ihamaki T, Siurala M. Long-term course and consequences of H. pylori gastritis. Scand J Gastroenterol 1996;31:546–50.
- Ihamaki T, Kekki M, Sipponen P, Siurala M. The sequelae and course of chronic gastritis during a 30 to 34 year bioptic followup study. Scand J Gastroenterol 1985;20:485–91.
- Klinkenberg-Knol EC, Festen HPM, Jansen JBMJ, Lamers CBHW, Nelis F, Snel P, et al. Long-term treatment with omeprazole for refractory reflux oesophagitis: efficacy and safety. Ann Intern Med 1994;121:161–7.
- Kuipers EJ, Perez-Perez GI, Meuwissen SGM, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cag A status. J Natl Cancer Inst 1995;87:1777–80.
- Logan RPH, Walker MM, Misiewicz JJ, Gummett PA, Karim QN, Baron JH. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995;36:12–6.
- Vigneri S, Termini R, Scialabba A, Savarino V, Di Mario F, Mela GS, et al. Omeprazole long-term treatment for duodenal ulcer: effect on the gastric distribution of Helicobacter pylori. Acta Gastroenterol Belg 1993;56:147.
- Peetsalu A, Maaroos HI, Sipponen P, Peetsalu M. Long-term effect of vagotomy on gastric mucosa and Helicobacter pylori in duodenal ulcer patients. Scand J Gastroenterol 1991;26:77–83.
- Lundell L, Havu N, Anderson A, Miettinen P, Myrvold HE, Pedersen SA, et al. Gastritis development and acid suppression therapy revisited: results of a randomised clinical study with long-term follow-up. Gastroenterology 1997;112:A28.
- Waldum HL, Petersen H, Brenna E. Gastrin and gastric cancer. Eur J Gastroenterol Hepatol 1992;4:801–11.